Evidence map›Paper›PMID 38329361›Full record

ArticleMicrobiology spectrum2024

Natural compounds from freshwater mussels disrupt fungal virulence determinants and influence fluconazole susceptibility in the presence of macrophages in

Davier Gutierrez-Gongora, Michael Woods, Ryan S Prosser, Jennifer Geddes-McAlister

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. A review of the current anti-New microbes and new infections · 2026
    Review
  2. Review
  3. Insights from Mass Spectrometry-Based Proteomics onJournal of fungi (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Combining Fluconazole with Benzo[Molecules (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Davier Gutierrez-GongoraDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.
Michael WoodsDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.
Ryan S ProsserSchool of Environmental Sciences, University of Guelph, Guelph, Ontario, Canada.
Jennifer Geddes-McAlisterDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.ORCID 0000-0002-4257-2096
University of Guelph · CA

Funding

Canada Research Chairs (Chaires de recherche du Canada)Canadian Foundation for Innovation JELF 38798Gouvernement du Canada | Canadian Institutes of Health Research (IRSC) Project GrantNSERC CREATE EvoFunPathOntario Graduate ScholarshipOntario Ministry of Colleges and Universities Early Researcher Award
6 · The paper itself

Abstract

IMPORTANCE: As the prevalence and severity of global fungal infections rise, along with an increasing incidence of antifungal resistance, new strategies to combat fungal pathogens and overcome resistance are urgently needed. Critically, our current methods to overcome fungal infections are limited and drive the evolution of resistance forward; however, an anti-virulence approach to disarm virulence factors of the pathogen and promote host cell clearance is promising. Here, we explore the efficacy of natural compounds derived from freshwater mussels against classical fungal virulence determinants, including thermotolerance, capsule production, stress response, and biofilm formation. We integrate our phenotypic discoveries with state-of-the-art mass spectrometry-based proteomics to identify mechanistic drivers of these antifungal properties and propose innovative avenues to reduce infection and support the treatment of resistant strains.

Indexed as

CryptococcosisCryptococcus neoformansAntifungal AgentsFluconazoleHumansMacrophagesVirulenceVirulence FactorsAntifungal AgentsFluconazoleVirulence FactorsantifungalsCryptococcus neoformansdrug resistanceextractsinvertebratesmusselsOne Healthquantitative proteomicsvirulence determinants

Identifiers

PMID38329361
PMCPMC10913472
OpenAlexW4391645052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.